Pharm Tech Minutes 2011.04.12-13: Difference between revisions
Jump to navigation
Jump to search
| (21 intermediate revisions by the same user not shown) | |||
| Line 34: | Line 34: | ||
== Greetings == | == Greetings == | ||
This minutes are available in '''[ftp://ftp.ihe.net/Pharmacy/Meetings/Meeting1314April2011/IHE-Pharmacy-Group-F2F-12-13-April-2011-Pisa.pdf pdf format - 17 pages]'''. | |||
=='''Presentation:''' XDW Profile== | =='''Presentation:''' XDW Profile== | ||
[ftp://ftp.ihe.net/Pharmacy/Meetings/Meeting1314April2011/XDW_slidesPisa_pharmacy.pdf Presentation PDF format - 11 slides] by Luca Zalunardo and Arianna Cocchiglia. | |||
=='''Report''' of vendors testing HMW profile== | =='''Report''' of vendors testing HMW profile== | ||
Representatives of vendors: | Representatives of vendors: | ||
* Solinfo (Italy) | ::* Solinfo (Italy) | ||
* Glintt (Portugal) | ::* Glintt (Portugal) | ||
* Dedalus (Italy) | ::* Dedalus (Italy) | ||
Report their feedback to the Pharmacy profiles and the Connectathon. | Report their feedback to the Pharmacy profiles and the Connectathon. | ||
== '''Presentation''': Status of ePrescription/eDispensation in epSOS == | == '''Presentation''': Status of ePrescription/eDispensation in epSOS == | ||
The presentation by Marcello Melgara was based on [http://www.epsos.eu/fileadmin/content/pdf/deliverables/D3.1.2_Final_Definition_of_Functional_Service_Requirements_ePrescription.pdf epSOS ePrescription : functional service requirements]. | :The presentation by Marcello Melgara was based on [http://www.epsos.eu/fileadmin/content/pdf/deliverables/D3.1.2_Final_Definition_of_Functional_Service_Requirements_ePrescription.pdf epSOS ePrescription : functional service requirements (pdf document)]. | ||
=='''Roadmap''': Discussing of Work-packages for 2011== | =='''Roadmap''': Discussing of Work-packages for 2011== | ||
| Line 56: | Line 57: | ||
* '''Clinical trials''' | * '''Clinical trials''' | ||
Linkage “Pharmacy” with current profiles dealing with clinical trial. | ::Linkage “Pharmacy” with current profiles dealing with clinical trial. | ||
'''Discussion''': Not most important, but in some hospitals a big time-consuming issue. | ::'''Discussion''': Not most important, but in some hospitals a big time-consuming issue. | ||
'''Decision''': Start with a whitepaper what is needed for TC. Not this year. | ::'''Decision''': Start with a whitepaper what is needed for TC. Not this year. | ||
* '''Handling instructions''' | * '''Handling instructions''' | ||
e.g. Cold chain, ... | e.g. Cold chain, ... | ||
'''Discussion''': If it’s an attribute of the product, of the supply chain or of part of Handling and Administration instructions. | ::'''Discussion''': If it’s an attribute of the product, of the supply chain or of part of Handling and Administration instructions. | ||
'''Question''': Shall Instructions be in prescriptions only or also in other documents. IHE must clarify the Technical Framework that this has been addressed. | ::'''Question''': Shall Instructions be in prescriptions only or also in other documents. IHE must clarify the Technical Framework that this has been addressed. | ||
'''Decision''': Low priority but small task - This period if possible | ::'''Decision''': Low priority but small task - This period if possible | ||
* '''Linkage to “Vaccines/Immunizations”''' | * '''Linkage to “Vaccines/Immunizations”''' | ||
'''Decision''': Important, but not this year! | ::'''Decision''': Important, but not this year! | ||
===CMPD / HMW=== | ===CMPD / HMW=== | ||
| Line 79: | Line 80: | ||
* '''Workflow''' | * '''Workflow''' | ||
Incorporate XDW Profile for missing workflow and status management -> Dependency issue with XDW roadmap. | ::Incorporate XDW Profile for missing workflow and status management -> Dependency issue with XDW roadmap. | ||
'''Discussion''': Very important especially for CMPD but a lot of work. Shall a whitepaper be written for the use of XDW in PHARM. | ::'''Discussion''': Very important especially for CMPD but a lot of work. Shall a whitepaper be written for the use of XDW in PHARM. | ||
'''Decision''': Urgent joint work XDW/PHARM beginning with a Whitepaper for use-cases. Confirmed by both WGs. | ::'''Decision''': Urgent joint work XDW/PHARM beginning with a Whitepaper for use-cases. Confirmed by both WGs. | ||
* '''Query current medication / Medication reconciliation''' | * '''Query current medication / Medication reconciliation''' | ||
'''Discussion''': It’s important how this is presented (text!). We can just deliver, what we “know” not what he actually “takes”. Be careful in phrasing this! Users have to be clear what they get and not get. HL7 introduced a “Medication statement”. Patient tells which medication he takes. | ::'''Discussion''': It’s important how this is presented (text!). We can just deliver, what we “know” not what he actually “takes”. Be careful in phrasing this! Users have to be clear what they get and not get. HL7 introduced a “Medication statement”. Patient tells which medication he takes. | ||
'''Decision''': Most important use-case, should be in this period | ::'''Decision''': Most important use-case, should be in this period | ||
* '''Substitution Handling: Exact Definition''' | * '''Substitution Handling: Exact Definition''' | ||
Exact task: Work out and exactly clarify what a “Substitution is”. | ::Exact task: Work out and exactly clarify what a “Substitution is”. | ||
Create samples. | ::Create samples. | ||
'''Decision''': In this period | ::'''Decision''': In this period | ||
*'''Use-case: Community - Hospital''' | *'''Use-case: Community - Hospital''' | ||
Connection to ''Query current medication'': At point of admission it shall be known the medication status | ::Connection to ''Query current medication'': At point of admission it shall be known the medication status | ||
Several use-cases. | ::Several use-cases. | ||
Is the current specification ready for covering these? | ::Is the current specification ready for covering these? | ||
'''Decision''': Creation of use-cases this period – then further decision | ::'''Decision''': Creation of use-cases this period – then further decision | ||
===CMPD only=== | ===CMPD only=== | ||
| Line 113: | Line 114: | ||
Results in writing specific use-cases and check if the current specification can handle them. | Results in writing specific use-cases and check if the current specification can handle them. | ||
'''Decision''': Some use-cases shall be created – then further decision | ::'''Decision''': Some use-cases shall be created – then further decision | ||
===CONTENT PROFILES=== | ===CONTENT PROFILES=== | ||
| Line 119: | Line 120: | ||
*'''Substitution-Structure''' | *'''Substitution-Structure''' | ||
There is still the open issue, that substitution handling could be stated different as current, using current HL7 MedicationOrder (PORX_RM010120UV) structures. | ::There is still the open issue, that substitution handling could be stated different as current, using current HL7 MedicationOrder (PORX_RM010120UV) structures. | ||
'''Open Issue''' | ::'''Open Issue''' | ||
This element might change. Structure is still in discussion with PCC and HL7 Structured Document group. | ::This element might change. Structure is still in discussion with PCC and HL7 Structured Document group. | ||
Derived from "MedicationOrder" CMET (PORX_RM010120UV). | ::Derived from "MedicationOrder" CMET (PORX_RM010120UV). | ||
http://www.hl7.org/v3ballot/html/domains/uvrx/editable/PORX_RM010120UV.htm | ::http://www.hl7.org/v3ballot/html/domains/uvrx/editable/PORX_RM010120UV.htm | ||
'''Decision''': Sidetrack, we have a solution. No pressure on it. Nice to have. | ::'''Decision''': Sidetrack, we have a solution. No pressure on it. Nice to have. | ||
*'''Non-medication products''' | *'''Non-medication products''' | ||
Same discussion in HL7. | ::Same discussion in HL7. | ||
'''Discussion''': There is currently no harmonization in non-medication products (braces, bandages etc.) medical devices on international level. Such products don’t have a number, etc. | ::'''Discussion''': There is currently no harmonization in non-medication products (braces, bandages etc.) medical devices on international level. Such products don’t have a number, etc. | ||
'''Decision''': JB will check the optionalities to check, if current specification could carry such items. Then further decision. | ::'''Decision''': JB will check the optionalities to check, if current specification could carry such items. Then further decision. | ||
*'''Preparations / Cytotoxics''' | *'''Preparations / Cytotoxics''' | ||
'''Problem''': Can be a mixture of everything (Products, Substances, other things). Problem is complex. | ::'''Problem''': Can be a mixture of everything (Products, Substances, other things). Problem is complex. | ||
'''Decision''': This period. | ::'''Decision''': This period. | ||
* '''Cancelling of already dispensed items which don’t have a prescription''' | * '''Cancelling of already dispensed items which don’t have a prescription''' | ||
'''Decision''': This period. | ::'''Decision''': This period. | ||
* '''How to deal with dispenses on behalf of pre which are not here yet''' | * '''How to deal with dispenses on behalf of pre which are not here yet''' | ||
'''Decision''': This period. | ::'''Decision''': This period. | ||
Jose volunteers. | ::Jose volunteers. | ||
===HMW only=== | ===HMW only=== | ||
| Line 156: | Line 157: | ||
* '''Message to be sent to many actors?''' | * '''Message to be sent to many actors?''' | ||
'''Decision''': Not this year. | ::'''Decision''': Not this year. | ||
* '''HL7v2 question: Insufficient fields for Order, Order session, Prescription ...''' | * '''HL7v2 question: Insufficient fields for Order, Order session, Prescription ...''' | ||
'''Decision''': Will be taken offline. Further discussed by Tom and Jose | ::'''Decision''': Will be taken offline. Further discussed by Tom and Jose | ||
* '''Administration report to dispenser – Purpose?''' | * '''Administration report to dispenser – Purpose?''' | ||
'''Decision''': High priority | ::'''Decision''': High priority | ||
* '''Prescription protocols''' | * '''Prescription protocols''' | ||
'''Decision''': Not much work, Jose volunteers | ::'''Decision''': Not much work, Jose volunteers | ||
* '''Cytotoxics''' | * '''Cytotoxics''' | ||
'''Discussion''': Impact on optionality, needs documenting. | ::'''Discussion''': Impact on optionality, needs documenting. | ||
'''Decision''': Should be this year. | ::'''Decision''': Should be this year. | ||
* '''Administration of perfusion''' | * '''Administration of perfusion''' | ||
'''Decision''': This year. | ::'''Decision''': This year. | ||
* '''Multiple systems in same hospital''' | * '''Multiple systems in same hospital''' | ||
e.g. Chemotherapy and normal pharmacy system | ::e.g. Chemotherapy and normal pharmacy system | ||
'''Decision''': Draft solution this year, to see if good for inclusion | ::'''Decision''': Draft solution this year, to see if good for inclusion | ||
* '''Documents in hospital system?''' | * '''Documents in hospital system?''' | ||
'''Discussion''': Too much work. This would result in a NEW profile. | ::'''Discussion''': Too much work. This would result in a NEW profile. | ||
'''Decision''': Not this year. Currently no volunteers. | ::'''Decision''': Not this year. Currently no volunteers. | ||
* '''Update to HL7v3 messages''' | * '''Update to HL7v3 messages''' | ||
'''Discussion''': Would probably result in a new profile. | ::'''Discussion''': Would probably result in a new profile. | ||
'''Decision''': Not this year. | ::'''Decision''': Not this year. | ||
* '''Supply chain''' | * '''Supply chain''' | ||
'''Discussion''': Big interest of vendors. It’s not about how to solve the supply chain, but how to “inform” the supply chain. A whitepaper should be written. Vendors should be involved. Is a cross-domain topic, possible liaison with ITI? | ::'''Discussion''': Big interest of vendors. It’s not about how to solve the supply chain, but how to “inform” the supply chain. A whitepaper should be written. Vendors should be involved. Is a cross-domain topic, possible liaison with ITI? | ||
'''Decision''': Whitepaper started this year. | ::'''Decision''': Whitepaper started this year. | ||
* '''Referentials / Formularies''' | * '''Referentials / Formularies''' | ||
'''Discussion''': It’s an implicit prerequisite in IHE to have common codelists and catalogs. Out of scope? Profiles should not require specific codesets, should be up to national extensions/specifications. | ::'''Discussion''': It’s an implicit prerequisite in IHE to have common codelists and catalogs. Out of scope? Profiles should not require specific codesets, should be up to national extensions/specifications. | ||
'''Decision''': This assumption is sufficient. | ::'''Decision''': This assumption is sufficient. | ||
* '''Exceptional cases''' | * '''Exceptional cases''' | ||
'''Discussion''': e.g.: Prescription is not validated by pharmacist, Medication cannot be dispensed, etc. | ::'''Discussion''': e.g.: Prescription is not validated by pharmacist, Medication cannot be dispensed, etc. | ||
Results in writing specific use-cases and check if the current specification can handle them. | ::Results in writing specific use-cases and check if the current specification can handle them. | ||
'''Decision''': Some use-cases shall be created – then further decision | ::'''Decision''': Some use-cases shall be created – then further decision | ||
== Prioritizing == | == Prioritizing == | ||
Changes in the [ | :Changes in the [ftp://ftp.ihe.net/Pharmacy/yr2_2010-2011/Planning%20Committee/IHE%20Pharmacy%20prios%202010-2011-summary.xls work plan 2011-2012 (xls file)] | ||
== '''Presentation''': “FamaSafe” == | == '''Presentation''': “FamaSafe” == | ||
Presentation by Lapo Bertini (Dedalus, Italy) about their implementation of Pharmacy hospital profiles. | :[ftp://ftp.ihe.net/Pharmacy/Meetings/Meeting1314April2011/WIP-FamaSafe-IHE-Pisa-2011-LB.pdf Presentation in PDF format - 10 slides] by Lapo Bertini (Dedalus, Italy) about their implementation of Pharmacy hospital profiles. | ||
==Planning next meetings == | ==Planning next meetings == | ||
| Line 233: | Line 232: | ||
* Paris/Vienna | * Paris/Vienna | ||
Date: 28.-29.06.2011 | ::Date: 28.-29.06.2011 | ||
* Vienna/Paris | * Vienna/Paris | ||
Date: 04.-05.10.2011 | ::Date: 04.-05.10.2011 | ||
Decision about Paris/Vienna switch triggered by Jacqueline depending on availability of guests. | ::Decision about Paris/Vienna switch triggered by Jacqueline depending on availability of guests. | ||
Report of Jacqueline about this until next week -> then decision. | ::Report of Jacqueline about this until next week -> then decision. | ||
===General compromise on future meeting places=== | ===General compromise on future meeting places=== | ||
| Line 254: | Line 253: | ||
===Next TCons=== | ===Next TCons=== | ||
Date: 24.05.2011 (moved from 19.05.2011), | :Date: 24.05.2011 (moved from 19.05.2011), | ||
Time: 12:00-13:30 Brussels time | :Time: 12:00-13:30 Brussels time | ||
===General decisions about TCons=== | ===General decisions about TCons=== | ||
Duration will be extended from 1 h to 1,5 h | :Duration will be extended from 1 h to 1,5 h | ||
==Miscellaneous== | ==Miscellaneous== | ||
=== Liaison with epSOS=== | === Liaison with epSOS=== | ||
Michiel Sprenger is involved in epSOS WP 2.2 “Strategy and Policy”, deals with roadmap views, etc. | :Michiel Sprenger is involved in epSOS WP 2.2 “Strategy and Policy”, deals with roadmap views, etc. | ||
He could be the link from IHE Pharmacy to epSOS. | :He could be the link from IHE Pharmacy to epSOS. | ||
'''Decision''': If this is an official liaison or informal will be checked by Robert Breas. | :'''Decision''': If this is an official liaison or informal will be checked by Robert Breas. | ||
=== Meeting requested by Nick Brown=== | === Meeting requested by Nick Brown=== | ||
Jacqueline Surugue received an email of Nick Brown (IHE UK). | :Jacqueline Surugue received an email of Nick Brown (IHE UK). | ||
He would like to meet Pharmacy group at CAT Pisa. | :He would like to meet Pharmacy group at CAT Pisa. | ||
Jürgen will do the meeting in Thursday. | :Jürgen will do the meeting in Thursday. | ||
Latest revision as of 11:03, 4 May 2011
Attendees
Tuesday, April 12.
- Ana Estelrich, Phast
- Arianna Cocchiglia, Arsenal.it
- Jacqueline Surugue, EAHP
- Jose Costa Teixeira, Agfa Healthcare
- Jürgen Brandstätter, CodeWerk
- Leonidas Tzimis, EAHP
- Luca Zalunardo, Arsenal.it
- Marc Robberecht, Agfa Healthcare
- Marco Demarmels Lake Griffin LLC
- Orlando Rodrigues, Glintt
- Robert Breas, NICTIZ
- Robert Horn, Agfa Healthcare
- Simon Letellier, EAHP
- Tom de Jong, HL7 Pharmacy
- Viktor Hafner, Austrian Pharmacists Association
Wednesday, April 13.
- Ana Estelrich, Phast
- Arianna Cocchiglia, Arsenal.it
- Geert Claeys, Agfa Healthcare
- Jacqueline Surugue, EAHP
- Jose Costa Teixeira, Agfa Healthcare
- Jürgen Brandstätter, CodeWerk
- Leonidas Tzimis, EAHP
- Luca Zalunardo, Arsenal.it
- Marc Robberecht, Agfa Healthcare
- Marco Demarmels Lake Griffin LLC
- Orlando Rodrigues, Glintt
- Robert Breas, NICTIZ
- Simon Letellier, EAHP
- Viktor Hafner, Austrian Pharmacists Association
Greetings
This minutes are available in pdf format - 17 pages.
Presentation: XDW Profile
Presentation PDF format - 11 slides by Luca Zalunardo and Arianna Cocchiglia.
Report of vendors testing HMW profile
Representatives of vendors:
- Solinfo (Italy)
- Glintt (Portugal)
- Dedalus (Italy)
Report their feedback to the Pharmacy profiles and the Connectathon.
Presentation: Status of ePrescription/eDispensation in epSOS
- The presentation by Marcello Melgara was based on epSOS ePrescription : functional service requirements (pdf document).
Roadmap: Discussing of Work-packages for 2011
COMMON
- Clinical trials
- Linkage “Pharmacy” with current profiles dealing with clinical trial.
- Discussion: Not most important, but in some hospitals a big time-consuming issue.
- Decision: Start with a whitepaper what is needed for TC. Not this year.
- Handling instructions
e.g. Cold chain, ...
- Discussion: If it’s an attribute of the product, of the supply chain or of part of Handling and Administration instructions.
- Question: Shall Instructions be in prescriptions only or also in other documents. IHE must clarify the Technical Framework that this has been addressed.
- Decision: Low priority but small task - This period if possible
- Linkage to “Vaccines/Immunizations”
- Decision: Important, but not this year!
CMPD / HMW
- Workflow
- Incorporate XDW Profile for missing workflow and status management -> Dependency issue with XDW roadmap.
- Discussion: Very important especially for CMPD but a lot of work. Shall a whitepaper be written for the use of XDW in PHARM.
- Decision: Urgent joint work XDW/PHARM beginning with a Whitepaper for use-cases. Confirmed by both WGs.
- Query current medication / Medication reconciliation
- Discussion: It’s important how this is presented (text!). We can just deliver, what we “know” not what he actually “takes”. Be careful in phrasing this! Users have to be clear what they get and not get. HL7 introduced a “Medication statement”. Patient tells which medication he takes.
- Decision: Most important use-case, should be in this period
- Substitution Handling: Exact Definition
- Exact task: Work out and exactly clarify what a “Substitution is”.
- Create samples.
- Decision: In this period
- Use-case: Community - Hospital
- Connection to Query current medication: At point of admission it shall be known the medication status
- Several use-cases.
- Is the current specification ready for covering these?
- Decision: Creation of use-cases this period – then further decision
CMPD only
- Exceptional cases
e.g.: Prescription is not validated by pharmacist, Medication cannot be dispensed, etc. Results in writing specific use-cases and check if the current specification can handle them.
- Decision: Some use-cases shall be created – then further decision
CONTENT PROFILES
- Substitution-Structure
- There is still the open issue, that substitution handling could be stated different as current, using current HL7 MedicationOrder (PORX_RM010120UV) structures.
- Open Issue
- This element might change. Structure is still in discussion with PCC and HL7 Structured Document group.
- Derived from "MedicationOrder" CMET (PORX_RM010120UV).
- http://www.hl7.org/v3ballot/html/domains/uvrx/editable/PORX_RM010120UV.htm
- Decision: Sidetrack, we have a solution. No pressure on it. Nice to have.
- Non-medication products
- Same discussion in HL7.
- Discussion: There is currently no harmonization in non-medication products (braces, bandages etc.) medical devices on international level. Such products don’t have a number, etc.
- Decision: JB will check the optionalities to check, if current specification could carry such items. Then further decision.
- Preparations / Cytotoxics
- Problem: Can be a mixture of everything (Products, Substances, other things). Problem is complex.
- Decision: This period.
- Cancelling of already dispensed items which don’t have a prescription
- Decision: This period.
- How to deal with dispenses on behalf of pre which are not here yet
- Decision: This period.
- Jose volunteers.
HMW only
- Message to be sent to many actors?
- Decision: Not this year.
- HL7v2 question: Insufficient fields for Order, Order session, Prescription ...
- Decision: Will be taken offline. Further discussed by Tom and Jose
- Administration report to dispenser – Purpose?
- Decision: High priority
- Prescription protocols
- Decision: Not much work, Jose volunteers
- Cytotoxics
- Discussion: Impact on optionality, needs documenting.
- Decision: Should be this year.
- Administration of perfusion
- Decision: This year.
- Multiple systems in same hospital
- e.g. Chemotherapy and normal pharmacy system
- Decision: Draft solution this year, to see if good for inclusion
- Documents in hospital system?
- Discussion: Too much work. This would result in a NEW profile.
- Decision: Not this year. Currently no volunteers.
- Update to HL7v3 messages
- Discussion: Would probably result in a new profile.
- Decision: Not this year.
- Supply chain
- Discussion: Big interest of vendors. It’s not about how to solve the supply chain, but how to “inform” the supply chain. A whitepaper should be written. Vendors should be involved. Is a cross-domain topic, possible liaison with ITI?
- Decision: Whitepaper started this year.
- Referentials / Formularies
- Discussion: It’s an implicit prerequisite in IHE to have common codelists and catalogs. Out of scope? Profiles should not require specific codesets, should be up to national extensions/specifications.
- Decision: This assumption is sufficient.
- Exceptional cases
- Discussion: e.g.: Prescription is not validated by pharmacist, Medication cannot be dispensed, etc.
- Results in writing specific use-cases and check if the current specification can handle them.
- Decision: Some use-cases shall be created – then further decision
Prioritizing
- Changes in the work plan 2011-2012 (xls file)
Presentation: “FamaSafe”
- Presentation in PDF format - 10 slides by Lapo Bertini (Dedalus, Italy) about their implementation of Pharmacy hospital profiles.
Planning next meetings
F2F meetings
- Paris/Vienna
- Date: 28.-29.06.2011
- Vienna/Paris
- Date: 04.-05.10.2011
- Decision about Paris/Vienna switch triggered by Jacqueline depending on availability of guests.
- Report of Jacqueline about this until next week -> then decision.
General compromise on future meeting places
- 3 F2F meetings per year:
- 1 at the CAT
- 1 at Paris or Brussels
- 1 at an “other” location
List of candidates for future F2F on “other” location
- Porto
- Amsterdam/Den Haag
- Treviso/Venice
Next TCons
- Date: 24.05.2011 (moved from 19.05.2011),
- Time: 12:00-13:30 Brussels time
General decisions about TCons
- Duration will be extended from 1 h to 1,5 h
Miscellaneous
Liaison with epSOS
- Michiel Sprenger is involved in epSOS WP 2.2 “Strategy and Policy”, deals with roadmap views, etc.
- He could be the link from IHE Pharmacy to epSOS.
- Decision: If this is an official liaison or informal will be checked by Robert Breas.
Meeting requested by Nick Brown
- Jacqueline Surugue received an email of Nick Brown (IHE UK).
- He would like to meet Pharmacy group at CAT Pisa.
- Jürgen will do the meeting in Thursday.